We have used the ACVR2B/Fc soluble receptor to test whether the inhibition of myostatin/activin A signaling might prevent or decrease skeletal muscle atrophy and restore muscle function in mouse models of HD. The gene discussed is MSTN; the disease is Huntington disease.